Eurofins Scientific Se
(OTC) ERFSF
Eurofins Scientific Se Financials at a Glance
Market Cap
$12.83B
Revenue (TTM)
$14.25B
Net Income (TTM)
$881.31M
EPS (TTM)
$2.87
P/E Ratio
24.37
Dividend
$0.68
Beta (Volatility)
0.59 (Low)
Dividend
$0.68
Beta (Volatility)
0.59 (Low)
Price
$72.62
Volume
12,047
Open
$73.88
Price
$72.62
Volume
12,047
Open
$73.88
Previous Close
$72.62
Daily Range
$68.17 - $73.88
52-Week Range
$48.55 - $86.20
Dividend
$0.68
Beta (Volatility)
0.59 (Low)
Price
$72.62
Volume
12,047
Open
$73.88
Previous Close
$72.62
Daily Range
$68.17 - $73.88
52-Week Range
$48.55 - $86.20
ERFSF News
ERFSF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Eurofins Scientific Se
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
65,694
CEO
Gilles G. Martin, PhD
Website
www.eurofins.comHeadquarters
Luxembourg City, 1526, LU
ERFSF Financials
Key Financial Metrics (TTM)
Gross Margin
16%
Operating Margin
16%
Net Income Margin
7%
Return on Equity
12%
Return on Capital
13%
Return on Assets
4%
Earnings Yield
4.10%
Dividend Yield
0.01%
Payout Ratio
12.23%
Stock Overview
Market Cap
$12.83B
Shares Outstanding
176.70M
Volume
12.05K
Short Interest
0.00%
Avg. Volume
6.26K
Financials (TTM)
Gross Profit
$792.70M
Operating Income
$792.70M
EBITDA
$1.45B
Operating Cash Flow
$1.29B
Capital Expenditure
$759.72M
Free Cash Flow
$534.80M
Cash & ST Invst.
$790.70M
Total Debt
$5.43B
Eurofins Scientific Se Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$3.68B
+11.4%
Gross Profit
$384.96M
-65.3%
Gross Margin
10.45%
N/A
Market Cap
$12.83B
N/A
Market Cap/Employee
$204.66K
N/A
Employees
62,696
N/A
Net Income
$228.31M
+43.8%
EBITDA
$630.96M
+13.8%
Quarterly Fundamentals
Net Cash
$4.64B
-71.8%
Accounts Receivable
$1.54B
+11.3%
Inventory
$138.95M
-0.0%
Long Term Debt
$4.70B
+41.4%
Short Term Debt
$726.73M
+20.9%
Return on Assets
4.32%
N/A
Return on Invested Capital
13.32%
N/A
Free Cash Flow
$250.81M
-26.2%
Operating Cash Flow
$789.30M
+25.8%